Back to Search Start Over

ADAMTS5 is a biomarker for prediction of response to infliximab in patients with rheumatoid arthritis.

Authors :
Tsuzaka K
Itami Y
Takeuchi T
Shinozaki N
Morishita T
Tsuzaka, Kensei
Itami, Yuka
Takeuchi, Tsutomu
Shinozaki, Naoshi
Morishita, Tetsuo
Source :
Journal of Rheumatology; Jul2010, Vol. 37 Issue 7, p1454-1460, 7p
Publication Year :
2010

Details

Language :
English
ISSN :
0315162X
Volume :
37
Issue :
7
Database :
Supplemental Index
Journal :
Journal of Rheumatology
Publication Type :
Academic Journal
Accession number :
105057843
Full Text :
https://doi.org/10.3899/jrheum.091285